Nurse-led consultations for managing chronic heart failure
Official title: Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients
Run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06853353 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests if having nurses lead consultations can help people with chronic heart failure manage their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Academic / other |
| Locations | 1 site (Toulon, Var) |
| Trial ID | NCT06853353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and over who are receiving nurse-led consultations for heart failure.
✕Probably not a fit
Patients who oppose participation in the study will not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of nurse-led consultations in managing chronic heart failure within a specific care pathway. It aims to address the challenges of treatment titration by utilizing advanced practice nursing and telemonitoring to improve patient outcomes. The study will involve patients who have participated in nurse-led consultations for heart failure during the specified period. By focusing on the role of heart failure specialist nurses, the study seeks to gather data on the impact of these consultations on patient care.
Why it matters
Potential benefit: If successful, this approach could enhance the management of chronic heart failure, leading to better patient outcomes and reduced morbidity.
How similar studies have gone: While there is limited data on the specific impact of nurse-led consultations in this context, similar approaches in chronic disease management have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years old or over * Patient seen in nurse-led consultations for heart failure between January 1, 2023 and December 31, 2023 Exclusion Criteria: * Patient opposition to participate in the study
Where it's running
-
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, France Recruiting
Study contacts
- Study coordinator: Magali CESANA
- Email: magali.cesana@ch-toulon.fr
- Phone: 04 83 77 20 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
-
Mobile-based telemedicine to improve quality of life for chronic heart failure patients
We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.
-
Restoring gut bacteria in adults with chronic heart failure
This trial tests whether replacing gut bacteria with healthy donor bacteria (intestinal microbiota transplantation) can reduce inflammation and improve function in adults with chronic heart failure.
-
Biventricular or left bundle branch pacing to improve heart pumping after TAVI
This research will try whether implanting a cardiac resynchronization device (biventricular or left bundle branch pacing) shortly after TAVI helps people who develop a persistent left bundle branch block and have mildly reduced heart function (EF 35%–55%).
-
Vericiguat for right‑ventricular function and heart remodeling in HFrEF
This study will test whether adding vericiguat to usual heart‑failure treatment helps adults with stable HFrEF improve right‑ventricular function and heart remodeling over 12 months.
-
Safety of finerenone in adults with chronic heart failure (LVEF ≥ 40%) in South Korea
This project will see if finerenone is safe for adults in South Korea who have chronic heart failure with a left ventricular ejection fraction of 40% or higher while they take it as usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.